조지아의 편두통 임상 시험
편두통 관련 연구 11개가 조지아 내 여러 지역에서 참여자를 모집하고 있습니다.
조지아의 도시
공식 연구 텍스트(영어)
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Evergreen Clinical Trials, Norcross
- Velocity Clinical Research, Savannah, Savannah
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT05156398Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Conquest Research, Atlanta
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07646613A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
피험자 모집 중1상
6세 ~ 11세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06995729Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
피험자 모집 중
10세 ~ 17세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- 외 1개
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
피험자 모집 중
22세 ~ 84세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07719608ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.